Specialty Pharmacy

Wayne Grau, vice president of Legislative Affairs at Managed Health Care Associates, discusses how specialty stakeholders can take steps to improve the perception surrounding specialty pharmacies following recent drug cost controversies.

Top news of the day from across the health care landscape.

ICER seeks comment on the effectiveness and value of disease modifying therapies for relapsing remitting and primary progressive multiple sclerosis.

Global HIV incidence rates drop in some African countries.

Top news of the week in oncology and cancer drug development.

Rates of suicide elevated in cancer survivors diagnosed before the age of 25 years.

Jury declares Merck’s acquired HCV drug patent valid.

The biosimilar epoetin was well-tolerated in elderly cancer patient populations.

FDA-approved drug could reduce the risk of death in adults with diabetes and cardiovascular disease.

Top news of the day from across the health care landscape.

Top articles of the week on Specialty Pharmacy Times.

Ceritinib (Zykadia) could potentially be used as a first-line treatment in patients with anaplastic lymphoma kinase-positive advanced non-small cell lung cancer.

Prior research suggested that T cells become pathogenic when they encounter specific dendritic cells in the lymph nodes.

The recommended time to begin antiretroviral therapy has changed since it first arrived in the mid 90s for HIV.

Study cautions against unintended consequences of “shock and kill” treatment for HIV.

New findings may lead to therapeutic options for stopping lung cancer cells from spreading to different parts of the body.

Top news of the day from across the health care landscape.

Sofosbuvir/ribavirin treatment is typically prescribed for 12 weeks, but for some patients with hepatitis C virus, a longer duration may be needed.

Crisaborole ointment (Eucrisa) treats mild to moderate eczema in patients 2 years and older.

Ultraviolet light may improve research into multiple sclerosis immune response and allow for the treatment of inflammatory diseases that spares healthy tissue.

Peer referrals for testing can locate people with undiagnosed HIV better than health care providers.

Increased presence of myocardial inflammation in patients with rheumatoid arthritis could be treated with non-TNFi biologic disease modifying anti-rheumatic drugs.

Treatment with Tecentriq helps successfully clear advanced lung cancer.

Celgene will continue trials with Abraxane plus immunotherapy drugs.

Alcohol could cause 7100 annual cancer deaths by 2035.

Blood test helps predict how aggressive lung cancer patients will respond to treatment.

Top news of the day from across the health care landscape.

Portal hypertension creates problems in patients coinfected with HIV and hepatitis C virus.

The combination drug Synjardy XR approved for use in patients with type 2 diabetes.

Switching from Glivec to Tasigna elicited a long-term response rate in patients with leukemia.